To examine the effects of stress on PFC function, male and female rats were exposed to different levels of mild stress, and then tested on a short-term memory task. The authors found that without stress, males and females performed equally well on the task. Likewise, after exposure to higher levels of stress, both males and females made significant memory errors. However, after exposure to a moderate level of stress, females were impaired, but males were not, suggesting that females were more sensitive to the PFC-impairing effects of stress. When the authors monitored the female rats' estrus cycles, they found that the rats showed this sensitivity only when they were in a high-estrogen phase. To further investigate the role of estrogen in this effect, Shansky et al removed the ovaries of a new group of female rats, thus eliminating any circulating estrogen. A time-release capsule containing either estrogen or placebo was implanted and the experiment repeated. Estrogen replacement had the same effect as naturally circulating estrogen--animals with estrogen capsules displayed the same sensitivity to stress that females in the high-estrogen estrus phase did, while animals with placebo capsules were unaffected.
Together, these results suggest that high levels of estrogen can act to enhance the stress response, causing greater stress-related cognitive impairments. It is important to note, however, that estrogen had no effect on cognitive performance under non-stressful conditions. The idea that estrogen could contribute to the higher prevalence of stress-related disorders in women is consistent with reports that the discrepancy first arises at puberty, maintains through the child-bearing years, and then declines, such that it is equally likely to occur in post-menopausal women as in men of the same age. The mechanisms by which estrogen may be producing these effects are to date unknown, but currently under investigation. It is known that estrogen can interact with molecular processes involved in the stress response, and that certain genetic variations have been demonstrated in clinically depressed women. However, how these factors might combine to produce the glaring disparity in the prevalence of this disorder awaits discovery. Such knowledge will hopefully lead to the development of new, more effective treatments for depression.
Citation source: Molecular Psychiatry advance online publication
For further information on this work, please contact Rebecca Shansky, Yale University School of Medicine, Department of Neurobiology, PO Box 208001, New Haven, Connecticut 06520-8001. Phone: (203) 785-3066, Fax: (203) 785-5263, E-mail: firstname.lastname@example.org
Molecular Psychiatry is published by the Nature Publishing Group. http://www.nature.com/mp
Editor: Julio Licinio, M.D.; phone: +1-310-825-7113; FAX: +1-310-206-6715; e-mail: email@example.com
For a copy of this article, please contact Aimee Midei, Editorial Assistant, e-mail: firstname.lastname@example.org.
PLEASE CITE MOLECULAR PSYCHIATRY AS THE SOURCE OF THIS MATERIAL
ARTICLE: "Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction"
AUTHORS: Rebecca M Shansky, Courtney Glavis-Bloom, David Lerman, Paulette McRae, Christopher Benson, Katherine Miller, Louise Cosand, Tamas L Horvath and Amy FT Arnsten